Fresenius: Q2 results in line with forecasts

(CercleFinance.com) - Fresenius and its subsidiary Fresenius Medical Care have reported unsurprising quarterly results just under a week after the publication of preliminary figures.


Fresenius reported Q2 net profit that is down 5% at 450 million euros on sales that are up 8% to just over 10 billion euros.

Fresenius Medical Care (FMC) - its subsidiary specialising in dialysis systems, which is also listed, reported net profit that is down 39% at 147 million euros over the period, based on revenues that are up 10% at 4.75 billion euros.

For the record, both Fresenius and FMC fell heavily on the stock market last Thursday after warning about their annual results.



Copyright (c) 2022 CercleFinance.com. All rights reserved.